6533b827fe1ef96bd1286f1a
RESEARCH PRODUCT
How sustainable are new treatment strategies for NSCLC?
Carlos CampsJordi RemonGilberto Lopessubject
Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyAcrylamidesAniline CompoundsLung Neoplasmsbusiness.industryCost-Benefit AnalysisMEDLINEAntineoplastic Agentsmedicine.diseaseAntibodies Monoclonal HumanizedText miningInternal medicineCarcinoma Non-Small-Cell LungMonoclonalmedicineCarcinomaTreatment strategyHumansbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2019-05-15 | The Lancet. Respiratory medicine |